Most Popular Stories
Webinars
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
Featured Jobs
-
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA -
Director, Global Regulatory CMC Job
Celgene Corporation - Basking Ridge, NJ, US -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ
Events
- Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York - DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - CALBIO2012: Driven By Patients - Marriott Marquis
March 8-9 — San Francisco, CA - BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Pharma 2.0: Heading Toward Social Media Marketing
- Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issue
- Best Practices: ERP Vendor Reference-Checking
- The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries
- The Voice of the Site Coordinator
- WHITE PAPER: Four Strategies for Cost-Effective Pharmacovigilance
FDA Commissioner Andrew von Eschenbach
